Etrinabdione oral solution
2023-509452-34-00
Phase 2 small_molecule active
Quick answer
Etrinabdione oral solution for Peripheral Arterial Disease is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Peripheral Arterial Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active